Halliday G - Search Results

1

Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease.

Kågedal K, Kim WS, Appelqvist H, Chan S, Cheng D, Agholme L, Barnham K, McCann H, Halliday G, Garner B. Kågedal K, et al. Among authors: halliday g. Biochim Biophys Acta. 2010 Aug;1801(8):831-8. doi: 10.1016/j.bbalip.2010.05.005. Epub 2010 May 16. Biochim Biophys Acta. 2010. PMID: 20497909

2

Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

Halliday GM, McCann HL, Pamphlett R, Brooks WS, Creasey H, McCusker E, Cotton RG, Broe GA, Harper CG. Halliday GM, et al. Acta Neuropathol. 1992;84(6):638-50. doi: 10.1007/BF00227741. Acta Neuropathol. 1992. PMID: 1281956

3

Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies.

Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Shepherd CE, et al. Among authors: halliday gm. Arch Neurol. 2000 Jun;57(6):817-22. doi: 10.1001/archneur.57.6.817. Arch Neurol. 2000. PMID: 10867778

4

Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease.

Halliday GM, Shepherd CE, McCann H, Reid WG, Grayson DA, Broe GA, Kril JJ. Halliday GM, et al. Arch Neurol. 2000 Jun;57(6):831-6. doi: 10.1001/archneur.57.6.831. Arch Neurol. 2000. PMID: 10867780 Clinical Trial.

5

Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.

Shepherd CE, Thiel E, McCann H, Halliday GM. Shepherd CE, et al. Among authors: halliday gm. Neurobiol Dis. 2001 Feb;8(1):136-46. doi: 10.1006/nbdi.2000.0361. Neurobiol Dis. 2001. PMID: 11162247

6

Corticobasal syndrome with tau pathology.

Cordato NJ, Halliday GM, McCann H, Davies L, Williamson P, Fulham M, Morris JG. Cordato NJ, et al. Among authors: halliday gm. Mov Disord. 2001 Jul;16(4):656-67. doi: 10.1002/mds.1124. Mov Disord. 2001. PMID: 11481689

7

Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.

Shepherd CE, McCann H, Thiel E, Halliday GM. Shepherd CE, et al. Neurobiol Dis. 2002 Mar;9(2):249-57. doi: 10.1006/nbdi.2001.0469. Neurobiol Dis. 2002. PMID: 11895376

8

Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease.

Münch G, Shepherd CE, McCann H, Brooks WS, Kwok JB, Arendt T, Hallupp M, Schofield PR, Martins RN, Halliday GM. Münch G, et al. Among authors: halliday gm. Neuroreport. 2002 Apr 16;13(5):601-4. doi: 10.1097/00001756-200204160-00013. Neuroreport. 2002. PMID: 11973454

9

Pick bodies in a family with presenilin-1 Alzheimer's disease.

Halliday GM, Song YJ, Lepar G, Brooks WS, Kwok JB, Kersaitis C, Gregory G, Shepherd CE, Rahimi F, Schofield PR, Kril JJ. Halliday GM, et al. Ann Neurol. 2005 Jan;57(1):139-43. doi: 10.1002/ana.20366. Ann Neurol. 2005. PMID: 15622541

10

Dolichol is the major lipid component of human substantia nigra neuromelanin.

Fedorow H, Pickford R, Hook JM, Double KL, Halliday GM, Gerlach M, Riederer P, Garner B. Fedorow H, et al. J Neurochem. 2005 Feb;92(4):990-5. doi: 10.1111/j.1471-4159.2004.02975.x. J Neurochem. 2005. PMID: 15686500 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

975 results

Search Page

Filters